Home > NY Providers > Hematologists

Dr. Ruben Niesvizky, MD

Accepting New Patients

(Ruben Niesvizky, M.D.)

(No ratings)

Specializes in: Hematology (Blood Disorders) and Medical Oncology

National Autonomous University of Mexico (UNAM) Faculty of Medicine (1985)

Professional interests include: myeloma, lymphoma, Waldenstrom macroglobulinemia, and more.

425 E 61st Street 8th Floor
New York, NY 10065

(646) 962-6500

Dr. Ruben Niesvizky, MD is a hematologist in New York, NY specializing in hematology (blood disorders) and medical oncology. He graduated from National Autonomous University of Mexico (UNAM) Faculty of Medicine in 1985 and has 40 years of experience. Dr. Ruben Niesvizky, MD is affiliated with NewYork-Presbyterian, Weill Cornell Medicine, WEILL MEDICAL COLLEGE OF CORNELL and Myeloma Center.

Office Locations

Address:

425 E 61st Street 8th Floor
New York, NY 10065

In The News

“Funeral service Sunday, 11:15 AM at ''The Riverside'' 76 St and Amsterdam Ave. Contributions in his memory may be made to The Joseph Michaeli Multiple Myeloma Research Fund at the New York...”—"Paid Notice: Deaths SCHINDLER, JOE P. (Published 2003)", New York Times, November 2003

“Funeral service Sunday, 11:15 AM at ''The Riverside'' 76th St and Amsterdam Ave. Contributions in his memory may be made to the Joseph Michaeli Multiple Myeloma Research Fund at the New York...”—"Paid Notice: Deaths SCHINDLER, JOE P. (Published 2003)", New York Times, November 2003

"https://weillcornell.org/news/achieving-myeloma-treatment-%E2%80%98milestones%E2%80%99-that-allow-patients-to-live-longer-and-improve-quality", Weill Cornell Medicine

aspiration	9
biological response modifier (BRM) therapy	584
blood draw	1237
bone marrow tests	25
chemotherapy	584
diagnostic procedures	26
doctor visit	1494
hospital care	171
inpatient care	171
minimally invasive procedures	789
preventive care	9
vaccines	9

**Gender**
Male	132
Female	107

**Ethnicity**
Non-Hispanic White	184
Black	20
Hispanic	22
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	121
From 75 to 84	75
85 and over	13
Less than 65	30

Hypertension	67
High Cholesterol	51
Stroke	5
Ischemic Heart Disease	46
Depression	28
Chronic Kidney Disease	45
Asthma	8
Osteoperosis	15
Atrial Fibrilation	10
Heart Failure	26
Chronic Obstructive Pulmonary Disease	11
Diabetes	34
Dementia	8
Cancer	15

biological response modifier (BRM) therapy	466
blood draw	809
chemotherapy	466
doctor visit	1237
hospital care	138
inpatient care	138
minimally invasive procedures	630
preventive care	11
vaccines	11

**Gender**
Male	111
Female	101

**Ethnicity**
Non-Hispanic White	155
Black	18
Hispanic	21
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	104
From 75 to 84	68
85 and over	14
Less than 65	26

Hypertension	68
High Cholesterol	50
Stroke	8
Ischemic Heart Disease	47
Depression	22
Chronic Kidney Disease	42
Asthma	0
Osteoperosis	12
Atrial Fibrilation	11
Heart Failure	29
Chronic Obstructive Pulmonary Disease	8
Diabetes	35
Dementia	8
Cancer	15

aspiration	36
biological response modifier (BRM) therapy	572
blood draw	1052
bone marrow tests	75
chemotherapy	572
diagnostic procedures	38
doctor visit	1526
hospital care	194
inpatient care	194
minimally invasive procedures	544
preventive care	16
vaccines	16

**Gender**
Male	250
Female	256

**Ethnicity**
Non-Hispanic White	380
Black	40
Hispanic	48
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	250
From 75 to 84	166
85 and over	40
Less than 65	50

Hypertension	62
High Cholesterol	51
Stroke	4
Ischemic Heart Disease	45
Depression	24
Chronic Kidney Disease	48
Asthma	6
Osteoperosis	18
Atrial Fibrilation	11
Heart Failure	32
Chronic Obstructive Pulmonary Disease	10
Diabetes	30
Dementia	9
Cancer	15

aspiration	20
biological response modifier (BRM) therapy	700
blood draw	1182
bone marrow tests	53
chemotherapy	700
diagnostic procedures	32
doctor visit	1608
hospital care	168
inpatient care	168
minimally invasive procedures	656

**Gender**
Male	137
Female	136

**Ethnicity**
Non-Hispanic White	206
Black	26
Hispanic	23
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	144
From 75 to 84	79
85 and over	18
Less than 65	32

Hypertension	62
High Cholesterol	50
Stroke	5
Ischemic Heart Disease	40
Depression	19
Chronic Kidney Disease	43
Asthma	8
Osteoperosis	14
Atrial Fibrilation	11
Heart Failure	31
Chronic Obstructive Pulmonary Disease	7
Diabetes	29
Dementia	9
Cancer	16

aspiration	35
biological response modifier (BRM) therapy	722
blood draw	1242
bone marrow tests	69
chemotherapy	722
diagnostic procedures	55
doctor visit	1597
hospital care	192
inpatient care	192
minimally invasive procedures	890

**Gender**
Male	153
Female	134

**Ethnicity**
Non-Hispanic White	221
Black	23
Hispanic	22
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	141
From 75 to 84	92
85 and over	27
Less than 65	27

Hypertension	66
High Cholesterol	43
Stroke	0
Ischemic Heart Disease	37
Depression	17
Chronic Kidney Disease	52
Asthma	7
Osteoperosis	13
Atrial Fibrilation	9
Heart Failure	31
Chronic Obstructive Pulmonary Disease	8
Diabetes	26
Dementia	11
Cancer	13

biological response modifier (BRM) therapy	507
blood draw	1121
chemotherapy	507
doctor visit	1406
hospital care	187
inpatient care	187
minimally invasive procedures	685

**Gender**
Male	123
Female	119

**Ethnicity**
Non-Hispanic White	181
Black	0
Hispanic	23
Asian	0
Other	17
Native American	0

**Age**
From 65 to 74	127
From 75 to 84	77
85 and over	19
Less than 65	19

Hypertension	60
High Cholesterol	53
Stroke	0
Ischemic Heart Disease	35
Depression	17
Chronic Kidney Disease	44
Asthma	7
Osteoperosis	17
Atrial Fibrilation	10
Heart Failure	28
Chronic Obstructive Pulmonary Disease	8
Diabetes	29
Dementia	9
Cancer	14

biological response modifier (BRM) therapy	577
blood draw	1352
chemotherapy	577
doctor visit	1432
hospital care	202
inpatient care	202
minimally invasive procedures	737

**Gender**
Male	143
Female	150

**Ethnicity**
Non-Hispanic White	223
Black	24
Hispanic	21
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	136
From 75 to 84	110
85 and over	31
Less than 65	16

biological response modifier (BRM) therapy	282
blood draw	793
chemotherapy	282
doctor visit	1258
hospital care	152
inpatient care	152
minimally invasive procedures	483

**Gender**
Male	121
Female	127

**Ethnicity**
Non-Hispanic White	181
Black	21
Hispanic	0
Asian	0
Other	19
Native American	0

**Age**
From 65 to 74	126
From 75 to 84	88
85 and over	22
Less than 65	12

Hypertension	62
High Cholesterol	46
Stroke	8
Ischemic Heart Disease	35
Depression	21
Chronic Kidney Disease	45
Asthma	6
Osteoperosis	17
Atrial Fibrilation	10
Heart Failure	33
Chronic Obstructive Pulmonary Disease	6
Diabetes	26
Dementia	11
Cancer	12

biological response modifier (BRM) therapy	261
blood draw	1219
chemotherapy	261
doctor visit	1343
hospital care	245
inpatient care	245
minimally invasive procedures	520
preventive care	22
vaccines	22

**Gender**
Male	128
Female	114

**Ethnicity**
Non-Hispanic White	182
Black	0
Hispanic	19
Asian	0
Other	21
Native American	0

**Age**
From 65 to 74	110
From 75 to 84	92
85 and over	28
Less than 65	12

Hypertension	57
High Cholesterol	52
Stroke	0
Ischemic Heart Disease	36
Depression	21
Chronic Kidney Disease	41
Asthma	6
Osteoperosis	17
Atrial Fibrilation	10
Heart Failure	30
Chronic Obstructive Pulmonary Disease	7
Diabetes	29
Dementia	11
Cancer	15

biological response modifier (BRM) therapy	332
blood draw	1287
chemotherapy	332
doctor visit	1550
hospital care	173
inpatient care	173
minimally invasive procedures	634
preventive care	16
vaccines	16

**Gender**
Male	151
Female	125

**Ethnicity**
Non-Hispanic White	205
Black	0
Hispanic	22
Asian	0
Other	25
Native American	0

**Age**
From 65 to 74	124
From 75 to 84	106
85 and over	31
Less than 65	15

Hypertension	68
High Cholesterol	68
Stroke	10
Ischemic Heart Disease	32
Depression	18
Chronic Kidney Disease	32
Asthma	13
Osteoperosis	25
Atrial Fibrilation	18
Heart Failure	24
Chronic Obstructive Pulmonary Disease	14
Diabetes	32
Dementia	8
Cancer	17

Average Medicare Procedure Volume From 2013 - 2022

Volume of procedures performed by Dr. Ruben Niesvizky, MD for Medicare patients.

The highest averages for the top procedures that Dr. Ruben Niesvizky, MD treated as a hematologist in New York, NY were blood draw, minimally invasive procedures, chemotherapy and biological response modifier (BRM) therapy.

aspiration	25
biological response modifier (BRM) therapy	501
blood draw	1129
bone marrow tests	56
chemotherapy	501
diagnostic procedures	38
doctor visit	1445
hospital care	182
inpatient care	182
minimally invasive procedures	656
preventive care	17
vaccines	17

Average Medicare Patient Data From 2013 - 2022

Information about Medicare patients treated by Dr. Ruben Niesvizky, MD.

**Gender**
Male	144
Female	136

**Ethnicity**
Black / African American	17
Asian / Pacific Islander	0
Non-Hispanic White	211
Native American / Alaskan Native	0
Hispanic	22
Other	8

**Age**
75 to 84	95
85 and over	24
Less than 65	23
65 to 74	138

Average of Total of Conditions of Medicare patients treated by Dr. Ruben Niesvizky, MD From 2013 - 2022

The highest averages of the most common conditions of Medicare patients that Dr. Ruben Niesvizky, MD treated were hypertension, high cholesterol, chronic kidney disease and ischemic heart disease.

Hypertension	63
High Cholesterol	51
Stroke	4
Ischemic Heart Disease	39
Depression	20
Chronic Kidney Disease	44
Asthma	6
Osteoporosis	16
Heart Failure	29
Chronic Obstructive Pulmonary Disease	8
Diabetes	29
Atrial Fibrillation	11
Cancer	14
Dementia	9

Education & Training

Dr. Ruben Niesvizky, MD graduated from National Autonomous University of Mexico (UNAM) Faculty of Medicine in 1985. He is certified by the American Board of Internal Medicine American Board of Internal Medicine (Hematology) and has a state license in New York.

Medical School: National Autonomous University of Mexico (UNAM) Faculty of Medicine (1985)

Board Certification: American Board of Internal Medicine American Board of Internal Medicine (Hematology)

Licensed In: New York

Affiliations & Hospitals

Dr. Ruben Niesvizky, MD is associated with these hospitals and organizations:

NewYork-Presbyterian

Weill Cornell Medicine

WEILL MEDICAL COLLEGE OF CORNELL

Myeloma Center

Insurance Information

Please note: Insurance information may change at any time, and the provider may accept your insurance plan even if it is not listed below. Please contact the provider's office to confirm that your insurance is accepted.

Dr. Ruben Niesvizky, MD appears to accept the following insurance providers: GHI, Health Insurance Plan of NY (HIP), AETNA, UnitedHealthcare, United Healthcare, Oxford Health Plans, CIGNA, Anthem Blue Cross/Blue Shield, Empire Blue Cross/Blue Shield, Aetna - NYP, VNSNY CHOICE, EmblemHealth, WellCare, Medicare Advantage, United Healthcare Empire Plan, United Healthcare Compass, Affinity Health Plan, Medicare, Medicaid, Fidelis Care, Healthfirst, Mediblue (Senior), EPO, Aetna Weill Cornell Employee Managed Care Plan, AgeWell New York, EPO/POS, WorldWide Medical, Aetna-NYP, Liberty, HMO, Aetna Weill Cornell Employee PPO Plan, Amida Care, Blue Access, Blue Connection, Rockefeller University - Trustmark, PPO, CBP, Community Plan, Freedom, Metro/Core/Charter and CHP.

Insurance Accepted by Provider includes:

According to our sources, Dr. Ruben Niesvizky, MD accepts the following insurance providers:

GHI

Health Insurance Plan of NY (HIP)

AETNA

UnitedHealthcare

United Healthcare

Oxford Health Plans

CIGNA

Anthem Blue Cross/Blue Shield

Empire Blue Cross/Blue Shield

Aetna - NYP

VNSNY CHOICE

EmblemHealth

WellCare

Medicare Advantage

United Healthcare Empire Plan

United Healthcare Compass

Affinity Health Plan

Medicare

Medicaid

Fidelis Care

Healthfirst

Mediblue (Senior)

EPO

Aetna Weill Cornell Employee Managed Care Plan

AgeWell New York

EPO/POS

WorldWide Medical

Aetna-NYP

Liberty

HMO

Aetna Weill Cornell Employee PPO Plan

Amida Care

Blue Access

Blue Connection

Rockefeller University - Trustmark

PPO

CBP

Community Plan

Freedom

Metro/Core/Charter

CHP

Show More

Ratings & Reviews

Dr. Ruben Niesvizky, MD does not have any reviews yet, be the first to leave a review of Dr. Ruben Niesvizky, MD here: Leave a Review

(No ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Ruben Niesvizky, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
Celgene Corporation	$438,601 Revlimid $192,311	Pomalyst $136,045	None $14,900	Reblozyl $131	BB-2121 $122	Other $95,092
Millennium Pharmaceuticals, Inc.	$230,738 VELCADE $82,637	NINLARO $56,957	$91,144
Amgen Inc.	$166,917 Kyprolis $151,620	Blincyto $5,249	XGEVA $2,613	$7,436
GlaxoSmithKline, LLC.	$99,170 BLENREP $3,475	$95,695
E.R. Squibb & Sons, L.L.C.	$84,462 EMPLICITI $62,312	ELIQUIS $11	$22,140
Other	$176,534 Kyprolis $57,257	DARZALEX $27,015	XPOVIO $21,775	NonCovered Product $4,600	ELREXFIO $3,500	Other $62,387

**Types of Payments**
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program	$665,052
Consulting Fee	$319,624
Travel and Lodging	$155,895
Food and Beverage	$32,389
Honoraria	$23,265
Other	$198

Research Payments

Dr. Ruben Niesvizky, MD has received 583 research payments totaling $8,065,000.

Biography

Dr. Ruben Niesvizky is a specialist in medical oncology and hematology (blood disorders). He works in New York, NY. These areas are among his clinical interests: waldenstrom macroglobulinemia, multiple myeloma, and amyloidosis. He is professionally affiliated with Weill Cornell Medicine and NewYork-Presbyterian. Dr. Niesvizky can take several insurance carriers, including United Healthcare Compass, Health Insurance Plan of New York (HIP), and Blue California. Weill Cornell Medicine reports that he is accepting new patients at his office in. He studied medicine at National Autonomous University of Mexico (UNAM) Faculty of Medicine. Dr. Niesvizky has received the following distinctions: The Leukemia and Lymphoma Society SCOR grant. Clinical Core; Translational Research Grant: Awarded by CTEP:NCI. RFP S03-058 SAIC-Frederick; and K23 Award: 1 K23 CA109260-01.EXPLOITING NOVEL THERAPEUTIC TARGETS IN MULTIPLE MYELOMA. Dr. Niesvizky (or staff) is conversant in Hebrew, Spanish, and Yiddish.